Anterogen Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Anterogen Co Ltd with three other
pharmaceutical manufacturers in Asia:
Vista Pharmaceuticals Limited
sales of 227.59 million Indian Rupees [US$3.07 million]
Parenteral Drugs (India) Ltd
(318.75 million Indian Rupees [US$4.30 million]
Zenotech Laboratories Limited
based in INDIA
(259.38 million Indian Rupees [US$3.50 million]
of which 99%
was Sale of services).
Sales were up sharply during the first
quarter of 2021 versus the previous year's first quarter.
During the first
quarter of 2021, sales at Anterogen Co Ltd totalled
1.48 billion Korean Won .
an increase of 64.3%
from the 903.27 million Korean Won in sales at the company during the first quarter of 2020.
This was the largest same quarter increase in sales since the first
quarter of 2016.
Anterogen Co Ltd reported sales of 4.15 billion Korean Won (US$3.66 million)
December of 2020.
a very small
increase of 0.1%
versus 2019, when the company's sales were 4.15 billion Korean Won .